Implant Critic Converts Government Crusade Into Business

A chemist who was fired by the Canadian health department after criticizing the Mime breast implant now consults on the issue OTTAWA--For J.J.B. Pierre Blais, doing good science has also turned out to be good for business. Two years after the Canadian chemist was fired from his country's health department in 1989 after his repeated attempts to have the MÆme breast implant removed from the market (The Scientist, September 4, 1989, page 7; also see accompanying story), Blais is running a b

Written byDavid Spurgeon
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

OTTAWA--For J.J.B. Pierre Blais, doing good science has also turned out to be good for business.

Two years after the Canadian chemist was fired from his country's health department in 1989 after his repeated attempts to have the MÆme breast implant removed from the market (The Scientist, September 4, 1989, page 7; also see accompanying story), Blais is running a burgeoning consulting practice built on advising physicians whose worried patients want their implants removed.

Blais never abandoned his campaign against the implant, which is coated with a material that laboratory tests have shown can degrade into a substance that causes cancer in laboratory animals. Last month his views gained support from the United States Food and Drug Administration, which has advised physicians to stop doing implantation surgery using the MÆme implant until the agency has completed a study of potential health risks of the polyurethane foam that coats the silicone ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies